Clinical Trial

Oral Immunonutrition Therapy to Reduce Acute Toxicity After Neoadjuvant Chemoradiotherapy Pancreatic Cancer Patients

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated December 17, 2024 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
A prospective, single-arm clinical trial is conducted to investigate the role of oral immunonutrion in reducing acute toxicity after neoadjuvant chemoradiotherapy among pancreatic cancer patients.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06736678
Lead Sponsor Sun Yat-sen University
Conditions Pancreatic Cancer, Neoadjuvant Chemoradiotherapy, Immunonutrition
Enrollment 98 participants
Start Date 2024-08-26
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-09-30 (estimated)
Updated on ClinicalTrials.gov 2024-12-17